✦ LIBER ✦

Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression

✍ Scribed by Wan, Hong I; Soares, Holly; Waring, Jeffrey F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical use of cerebrospinal fluid biom

✍ Zetterberg, Henrik; Lunn, Michael P; Herukka, Sanna-Kaisa 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 486 KB

Use of cerebrospinal fluid biomarkers in

✍ J. Hort; A. Bartos; T. Pirttilä; P. Scheltens 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Cerebrospinal fluid levels of orexin-A a

✍ M Björkqvist; Å Petersén; J Nielsen; D Ecker; H Mulder; MR Hayden; B Landwehrmey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost-Effectiveness of the Use of Biomark

✍ Valcárcel-Nazco, Cristina ;Perestelo-Pérez, Lilisbeth ;Molinuevo, José Luis ;Mar 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 354 KB

Cerebrospinal fluid biomarker outcomes i

✍ Joseph F. Quinn; Ronald Thomas; Rema Raman; Karin Yurko-Mauro; Eileen Bailey-Hal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Validation and quantitation of proteomic

✍ Errol Norwitz; Lawrence Tsen; Joong-Shin Park; Patricia Fitzpatrick; David Dorfm 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 72 KB